Connect Biopharma Holdings Ltd (CNTB) — Cash Flow Quality Index
Latest as of June 2024:
-1.35x
Connect Biopharma Holdings Ltd (CNTB) has a Cash Flow Quality Index of -1.35x as of June 2024. Operating cash flow of $-8.29 Million is below net income of $6.15 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Connect Biopharma Holdings Ltd (CNTB) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-1.35x
Operating CF / Net Income
Operating Cash Flow
$-8.29 Million
USD
Net Income
$6.15 Million
USD
Data as of
Jun 2024
Most recent filing
Annual Cash Flow Quality Index for Connect Biopharma Holdings Ltd (None–None)
Year-by-year earnings quality comparison for Connect Biopharma Holdings Ltd. For live market cap and the full company financial profile, see CNTB company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.